Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21420
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vrtala, S. | en |
dc.contributor.author | Hirtenlehner, K. | en |
dc.contributor.author | Susani, M. | en |
dc.contributor.author | Akdis, M. | en |
dc.contributor.author | Kussebi, F. | en |
dc.contributor.author | Akdis, C. A. | en |
dc.contributor.author | Blaser, K. | en |
dc.contributor.author | Hufnagl, P. | en |
dc.contributor.author | Binder, B. R. | en |
dc.contributor.author | Politou, A. | en |
dc.contributor.author | Pastore, A. | en |
dc.contributor.author | Vangelista, L. | en |
dc.contributor.author | Sperr, W. R. | en |
dc.contributor.author | Semper, H. | en |
dc.contributor.author | Valent, P. | en |
dc.contributor.author | Ebner, C. | en |
dc.contributor.author | Kraft, D. | en |
dc.contributor.author | Valenta, R. | en |
dc.date.accessioned | 2015-11-24T19:14:56Z | - |
dc.date.available | 2015-11-24T19:14:56Z | - |
dc.identifier.issn | 0892-6638 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21420 | - |
dc.rights | Default Licence | - |
dc.subject | Allergens/genetics/*immunology | en |
dc.subject | Antigens, Plant | en |
dc.subject | Cell Division | en |
dc.subject | Cells, Cultured | en |
dc.subject | Cytokines/metabolism | en |
dc.subject | Epitopes, B-Lymphocyte/immunology | en |
dc.subject | Epitopes, T-Lymphocyte/immunology | en |
dc.subject | Genetic Engineering | en |
dc.subject | Humans | en |
dc.subject | Immunoglobulin E/immunology | en |
dc.subject | Immunoglobulin G/immunology | en |
dc.subject | Plant Proteins/genetics/*immunology | en |
dc.subject | Recombinant Proteins/genetics/immunology | en |
dc.subject | T-Lymphocytes/cytology/*immunology | en |
dc.subject | Th1 Cells/immunology | en |
dc.title | Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1 | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | 10.1096/fj.00-0767fje | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/11511511 | - |
heal.identifier.secondary | http://www.fasebj.org/content/early/2001/09/02/fj.00-0767fje.full.pdf | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2001 | - |
heal.abstract | An estimated 100 million individuals suffer from birch pollen allergy. Specific immunotherapy, the only curative allergy treatment, can cause life-threatening anaphylactic side effects. Here, we report the genetic engineering of a recombinant trimer consisting of three covalently linked copies of the major birch pollen allergen, Bet v 1. The trimer exhibited profoundly reduced allergenic activity but contained similar secondary structures such as Bet v 1 wild type, Bet v 1-specific B cell and T-cell epitopes, and induced Th1 cytokine release. As immunogen, rBet v 1 trimer induced IgG antibodies, which blocked patients' IgE binding to Bet v 1 and related allergens. Thus, rBet v 1 trimer represents a novel hypoallergenic vaccine prototype for treatment of one of the most frequent allergy forms. | en |
heal.journalName | Faseb Journal | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Vrtala-2001-Genetic engineering.pdf | 1.18 MB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License